Hadaya Karine, Fehr Thomas, Rüsi Barbara, Ferrari-Lacraz Sylvie, Jean Villard, Ferrari Paolo
Service of Nephrology. Geneva University Hospital, Geneva, Switzerland; Service of Transplantation, Geneva University Hospital, Geneva, Switzerland.
Service of Nephrology and Histocompatibility laboratory, Zurich University Hospital, Switzerland.
Swiss Med Wkly. 2015 Mar 5;145:w14083. doi: 10.4414/smw.2015.14083. eCollection 2015.
Growing incidence of end-stage renal disease, shortage of kidneys from deceased donors and a better outcome for recipients of kidneys from living donor have led many centres worldwide to favour living donor kidney transplantation programmes. Although criteria for living donation have greatly evolved in recent years with acceptance of related and unrelated donors, an immunological incompatibility, either due to ABO incompatibility and/or to positive cross-match, between a living donor and the intended recipient, could impede up to 40% of such procedures. To avoid refusal of willing and healthy living donors, a number of strategies have emerged to overcome immunological incompatibilities. Kidney paired donation is the safest way for such patients to undergo kidney transplantation. Implemented with success in many countries either as national or multiple regional independent programmes, it could include simple exchanges between any number of incompatible pairs, incorporate compatible pairs and non-directed donors (NDDs) to start a chain of compatible transplantations, lead to acceptance of ABO-incompatible matching, and integrate desensitising protocols. Incorporating all variations of kidney paired donation, the Australian programme has been able to facilitate kidney transplantation in 49% of registered incompatible pairs. This review is a plea for implementing a national kidney paired donation programme in Switzerland.
终末期肾病发病率不断上升、 deceased捐赠者的肾脏短缺以及活体捐赠者肾脏受者的更好预后,促使全球许多中心倾向于开展活体捐赠者肾脏移植项目。尽管近年来随着对亲属和非亲属捐赠者的接受,活体捐赠的标准有了很大发展,但活体捐赠者与预期受者之间的免疫不相容性,无论是由于ABO血型不相容和/或交叉配血阳性,都可能阻碍高达40%的此类手术。为了避免拒绝愿意且健康的活体捐赠者,已经出现了一些策略来克服免疫不相容性。肾脏配对捐赠是此类患者进行肾脏移植的最安全方式。在许多国家,作为国家或多个地区独立项目成功实施,它可以包括任意数量不相容对之间的简单交换,纳入相容对和非定向捐赠者(NDDs)以启动一系列相容移植,促成ABO血型不相容匹配的接受,并整合脱敏方案。澳大利亚的项目纳入了肾脏配对捐赠的所有变体,已能够为49%登记的不相容对提供肾脏移植便利。本综述呼吁在瑞士实施全国性肾脏配对捐赠项目。